Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.546 USD | +7.04% | +2.18% | +1.93% |
Mar. 22 | Sangamo Therapeutics Prices $24 Million Registered Direct Offering | MT |
Mar. 14 | Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.93% | 106M | |
-0.12% | 103B | |
+3.21% | 96.73B | |
+1.66% | 21.31B | |
-15.88% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-21.91% | 13.68B | |
+6.57% | 13.44B | |
+23.81% | 10.98B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Sangamo Therapeutics : Wedbush Trims Price Target for Sangamo Therapeutics to $11 From $12, Maintains Neutral Rating